Kenya Medical Supplies Authority (KEMSA) has affirmed its commitment in acquiring title deeds of all pieces of land belonging to the Authority by end of this month.
The CEO Dr. Jonah Manjari said the Board has taken up the issue and has engaged
Conveyance experts to ensure that the title deeds are acquired within the specified time
Dr. Manjari was a responding to a media report from the Auditor General for the
financial year ended June 2018, where KEMSA is said to be at risk of losing parcels of land in different parts of the country for which it does not have ownership documents.
“We expect to have the title deeds for Kakamega, Kisumu, and Eldoret parcels of land by end of June 2019,” he noted.
The report also questioned stocking of expired drugs valued at Sh150 million and the expenditure of Sh8M by the Authority’s board of directors on sitting and lunch
Dr. Manjari clarified that with the change of KEMSA’s business model from PULL to
PUSH system, some commodities attracted little or no demand from the public health
facilities hence over time exhausted their shelf life and became obsolete.
He also attributed the expiries to change in treatment regimens effected through policy changes and adoption of new technologies in healthcare from analogue-based to digital-based diagnosis in radiology which rendered X-ray films and processing
“Some drugs under the old treatment regimen became obsolete due to change of
treatment protocol such as shifts to better and more efficacious treatment regimens,” he stressed.
The CEO remarked that through demand and planning, KEMSA ensures accurate
forecasting and quantification are done according to the needs of the counties "We wish to assure the public that no expired drugs have been supplied and KEMSA is committed and will remain committed to ensuring that the quality standards in procuring, warehousing and distribution of all health products and technologies is upheld," said Dr Manjari.
In reference to Board expenses, Dr. Manjari said KEMSA stayed without a substantive board Chair and Chief Executive Officer for a long period of time.
During this period, there were increased board activities and consultations that required the presence of the board Session Chair and one member of the board on various ongoing developments within the organization.
“We therefore confirm that no sitting allowance was paid to a board member
undeservingly,” he stated.
KEMSA remains committed to provide reliable, affordable and quality health care to all Kenyans in an accountable and transparent manner.